To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio video software.
|
Webcast Link: |
|
|
Teleconference Domestic: |
888-506-0062 |
|
Teleconference International: Participant Access Code: |
973-528-0011 784818 |
|
Webcast Replay Expiration: |
Friday, May 19, 2023 |
|
Teleconference Replay Expiration: |
Thursday, June 02, 2022 |
|
Teleconference Replay Domestic: |
877-481-4010 |
|
Teleconference Replay International: |
919-882-2331 |
|
Replay Passcode: |
45648 |
About
BioLargo, Inc.
BioLargo,
Inc. (OTCQB:BLGO) invents, develops, and commercializes innovative technologies
in the cleantech space, including for PFAS contamination, advanced water and
wastewater treatment, industrial odor and VOC control, air quality control, and
infection control. With over 13 years of extensive R&D, BioLargo holds a
wide array of issued patents, maintains a robust pipeline of products, and
provides full-service environmental engineering. Our approach is to invent or
acquire novel technologies and develop them to maturity through our operating
subsidiaries. We have developed a number of key channel partnerships to support
the reach of our products and services and maximize their commercial potential.
With a keen emphasis on collaborations with academic, municipal, and commercial
organizations and associations, BioLargo has proven itself with over 80 awarded
grants and numerous pilot projects. We monetize through direct sales, recurring
service contracts, licensing agreements, strategic joint venture formation
and/or the sale of the IP. See our website at www.BioLargo.com.
Dennis
P. Calvert
President
and CEO, BioLargo, Inc.
888-400-2863
Safe
Harbor Act
This press
release contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements
include without limitation those about BioLargo’s (the “Company”) expectations
regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans
for future operations. These statements involve risks and uncertainties, and
actual results may differ materially from any future results expressed or
implied by the forward-looking statements. Risks and uncertainties include
without limitation: the effect of the COVID-19 pandemic on the Company’s
business, results of operations, financial condition, and stock price; the
effect of regional economic conditions on the Company’s business, including
effects on purchasing decisions by consumers and businesses; the ability of the
Company to compete in markets that are highly competitive and subject to rapid
technological change; the ability of the Company to manage frequent
introductions and transitions of products and services, including delivering to
the marketplace, and stimulating customer demand for, new products, services,
and technological innovations on a timely basis; the dependency of the Company
on the performance of distributors of the Company’s products. More information
on these risks and other potential factors that could affect the Company’s
business and financial results is included in the Company’s filings with the
SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” sections of the Company’s
most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent
filings. The Company assumes no obligation to update any forward-looking
statements or information, which speak as of their respective dates.
No comments:
Post a Comment